Back
Marker Therapeutics Stock Price Chart
Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings
Analyze Any Stock Free
Sell
20
MRKR
Marker Therapeutics
Last Price:
$2.51
Seasonality Move:
14.01%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRKR is experiencing selling pressure, which indicates risk of future bearish movement.
Marker Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.94 | Sell |
| 20-day SMA: | 3.41 | Sell |
| 50-day SMA: | 3.51 | Sell |
| 200-day SMA: | 3.88 | Sell |
| 8-day EMA: | 2.9 | Sell |
| 20-day EMA: | 3.22 | Sell |
| 50-day EMA: | 3.42 | Sell |
| 200-day EMA: | 3.72 | Sell |
Marker Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 34.31 | Sell |
| Chaikin Money Flow: | -16394 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.96 - 4.1) | Sell |
| Bollinger Bands (100): | (2.82 - 3.9) | Sell |
Marker Therapeutics Technical Analysis
| Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marker Therapeutics Stock
Is Marker Therapeutics Stock a Buy?
-
Marker Therapeutics share price is 2.54 while MRKR 8-day simple moving average is 2.94, which is a Sell signal.
-
The stock price of MRKR is 2.54 while Marker Therapeutics 20-day SMA is 3.41, which makes it a Sell.
-
Marker Therapeutics 50-day simple moving average is 3.51 while MRKR share price is 2.54, making it a Sell technically.
-
MRKR stock price is 2.54 and Marker Therapeutics 200-day simple moving average is 3.88, creating a Sell signal.
MRKR Technical Analysis vs Fundamental Analysis
Sell
20
Marker Therapeutics (MRKR)
is a Sell
Is Marker Therapeutics a Buy or a Sell?
-
Marker Therapeutics stock is rated a SellThe current Marker Therapeutics [MRKR] share price is $2.54. The Score for MRKR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Marker Therapeutics Stock Info
Market Cap:
27.2M
Price in USD:
2.54
Share Volume:
26.5K
Marker Therapeutics 52-Week Range
52-Week High:
5.99
52-Week Low:
2.44
Sell
20
Marker Therapeutics (MRKR)
is a Sell
Marker Therapeutics Share Price Forecast
-
What is the Marker Therapeutics stock price today?The Marker Therapeutics stock price is 2.54 USD today.
-
Will MRKR stock go up or go down?Marker Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Marker Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marker Therapeutics is overvalued.
Is Marker Therapeutics Stock a Buy?
-
Marker Therapeutics share price is 2.54 while MRKR 8-day exponential moving average is 2.90, which is a Sell signal.
-
The stock price of MRKR is 2.54 while Marker Therapeutics 20-day EMA is 3.22, which makes it a Sell.
-
Marker Therapeutics 50-day exponential moving average is 3.42 while MRKR share price is 2.54, making it a Sell technically.
-
MRKR stock price is 2.54 and Marker Therapeutics 200-day simple moving average is 3.72, creating a Sell signal.
Fundamental Analysis of Marker Therapeutics
Is Marker Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.14 per share, and a decrease next year of $0.40 per share.
Technical Analysis of Marker Therapeutics
Should I short Marker Therapeutics stock?
-
MRKR Moving Average Covergence Divergence (MACD) indicator is -0.25, suggesting Marker Therapeutics is a Sell
-
Marker Therapeutics Relative Strength Index (RSI) is 34.31, which suggest Marker Therapeutics is oversold
-
The Bollinger Bands (25) for Marker Therapeutics is (2.96 - 4.1), which suggest Marker Therapeutics is a Sell
-
The Bollinger Bands (100) for Marker Therapeutics is (2.82 - 3.9), which suggest Marker Therapeutics is a Sell
* Marker Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.